prior authorization for glp 1 🚨 A new Medicare program could expand access to GLP-1 weight-loss medications starting in 2026. Med Spas offering physician-supervised -1 programs, this could lead to more patients asking about eligibility and Administrative costs of prior authorizations

It has been linked to enhanced vessel formation and reepithelialization through modulation of cytoskeletal organization and integrinlinked signaling pathways

(source) A 2017 meta-analysis did not support the suggestion that treatment with GLP-1 agonists or DPP-4 inhibitors increased all-cause mortality in type 2 diabetics

Mitochondrial Dysfunction Can Restrict Methylation at Several Points Important precision: mitochondrial dysfunction does not directly clear homocysteine or adenosine through one reaction

[No authors listed] Altern Med Rev

For the new study, researchers tracked insurance claims from nearly 127,000 overweight or obese adults who started GLP-1 treatment between 2019 and 2024, looking for people taking drugs like semaglutide (Ozempic/Wegovy), tirzepatide (Zepbound/Mounjaro), or liraglutide (Saxenda/Victoza)

They can refer their own employer directly at andel.org/referral